A
Abdera combines advanced antibody engineering with radiotherapeutics to create targeted cancer medicines. The company utilizes its ROVEr platform to develop novel radiopharmaceuticals that deliver radionuclide payloads against solid tumor targets. This approach focuses on maximizing therapeutic effect while mitigating systemic toxicities associated with cancer treatment.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Abdera combines advanced antibody engineering with radiotherapeutics to create targeted cancer medicines. The company utilizes its ROVEr platform to develop novel radiopharmaceuticals that deliver radionuclide payloads against solid tumor targets. This approach focuses on maximizing therapeutic effect while mitigating systemic toxicities associated with cancer treatment.